oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Konaten

for 7 of 41 batches marketed in Poland, out‑of‑specification results for atomoxetine content were found in reference samples, below the lower specification limit; the medical risk assessment indicated possible low effectiveness of the medicine. Potential effects: reduced therapeutic efficacy, risk of lack of the expected treatment effect.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Konaten
Risk Level
Low
Manufacturer
neuraxpharm Arzneimittel GmbH z siedzibą w Niemczech
Batch Number
1110197
EAN Code
05909991390990
Recall Date
28.08.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use the medicine from the listed batches; check the batch number on the packaging and, if you possess the product, return it to a pharmacy or consult a doctor or pharmacist for further advice.

Actions Taken

The specified batches of the medicinal product Konaten (Atomoxetine) were withdrawn from the market throughout the country, marketing of these batches was prohibited, and the decision was given immedi...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: for 7 of 41 batches marketed in Poland, out‑of‑specification results for atomoxetine content were found in reference samples, below the lower specification limit; the medical risk assessment indicated possible low effectiveness of the medicine. Potential effects: reduced therapeutic efficacy, risk of lack of the expected treatment effect.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 1110197

Related

Other Recalled Products